After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
The Directorate of Foreign Trade (DGFT) has taken a big decision on the rigging in the export of
Aamir Khan is happy these days about the success of his film 'Sitare Zameen Par'. Recently he has
Harsh Vardhan Stuck by launching Ramdev'sck coronil, IMA asked for clarification
The Indian Medical Association (IMA) on Monday sought an explanation from Union Health Minister D
The Supreme Court has again slammed the Center for returning its recommendations for the appointm
Kannada superstar Yash's highly anticipated film 'Toxic' is getting embroiled in one controversy
The Defense Ministry of India is at the forefront of the world in terms of providing jobs or empl
Fluctuations in weather activities continue in many states of the country. At the same time, the
E-Pharmacy: Preparation to curb e-pharmacy, Union Health Ministry may take big action
E Pharmacy under Radar Union Health Ministry is going to take strict action against the misuse of
Climate change is not only affecting the production of crops, but their quality is also having a
After the conviction of Congress leader Rahul Gandhi in the defamation case, the BJP is continuou
